{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:59:12Z","timestamp":1794027552505,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.molmed.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:19:07Z","timestamp":1723551547000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Leveraging insights from cancer to improve tuberculosis therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-8992","authenticated-orcid":false,"given":"Meenal","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Via","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Clifton E.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.07.011_bb0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1101\/gad.314849.118","article-title":"Molecular mechanisms of the preventable causes of cancer in the United States","volume":"32","author":"Golemis","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2024.07.011_bb0010","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein-Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.molmed.2024.07.011_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/2278-330X.96507","article-title":"Pulmonary tuberculosis as differential diagnosis of lung cancer","volume":"1","author":"Bhatt","year":"2012","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.molmed.2024.07.011_bb0020","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.21037\/tcr-21-1719","article-title":"Differentiating mass-like tuberculosis from lung cancer based on radiomics and CT features","volume":"10","author":"Wei","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.molmed.2024.07.011_bb0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/jcm11030765","article-title":"Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis","volume":"11","author":"Hwang","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321336121","article-title":"Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits","volume":"121","author":"Datta","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.07.011_bb0035","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"Datta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.07.011_bb0040","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.celrep.2019.04.072","article-title":"VEGF-A from granuloma macrophages regulates granulomatous inflammation by a non-angiogenic pathway during mycobacterial infection","volume":"27","author":"Harding","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.07.011_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4432","article-title":"Mycobacterium tuberculosis dysregulates MMP\/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation","volume":"235","author":"Kubler","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0050","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature13967","article-title":"Interception of host angiogenic signalling limits mycobacterial growth","volume":"517","author":"Oehlers","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.07.011_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41598-023-27895-8","article-title":"Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity","volume":"13","author":"Sampath","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2024.07.011_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.chom.2018.09.004","article-title":"Cyclopropane modification of trehalose dimycolate drives granuloma angiogenesis and mycobacterial growth through Vegf signaling","volume":"24","author":"Walton","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2024.07.011_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2017.06.017","article-title":"Identifying mechanisms driving formation of granuloma-associated fibrosis during Mycobacterium tuberculosis infection","volume":"429","author":"Warsinske","year":"2017","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018499","article-title":"Immunity and Immunopathology in the tuberculous granuloma","volume":"5","author":"Pag\u00e1n","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2024.07.011_bb0080","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0085","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1462-5822.2009.01325.x","article-title":"Hypoxia: a window into Mycobacterium tuberculosis latency","volume":"11","author":"Rustad","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0090","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/thoraxjnl-2015-207402","article-title":"Hypoxia and tissue destruction in pulmonary TB","volume":"71","author":"Belton","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.molmed.2024.07.011_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1164\/rccm.202202-0393ED","article-title":"Treatments of multidrug-resistant tuberculosis: light at the end of the tunnel","volume":"205","author":"Lange","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021196","article-title":"Host-directed therapies for tuberculosis","volume":"5","author":"Tobin","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2024.07.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.07.011_bb0135","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don\u2019t know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.07.011_bb0140","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/AAC.00531-12","article-title":"Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [18F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography","volume":"56","author":"Via","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molmed.2024.07.011_bb0145","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820134","article-title":"In the thick of it: formation of the tuberculous granuloma and its effects on host and therapeutic responses","volume":"13","author":"Cronan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0155","article-title":"Automated quantitative assay of fibrosis characteristics in tuberculosis granulomas","volume":"14","author":"Song","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0160","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fimmu.2020.00419","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases are potential biomarkers of pulmonary and extra-pulmonary tuberculosis","volume":"11","author":"Kathamuthu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008520","article-title":"Systems biology predicts that fibrosis in tuberculous granulomas may arise through macrophage-to-myofibroblast transformation","volume":"16","author":"Evans","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molmed.2021.11.004","article-title":"Understanding the tuberculosis granuloma: the matrix revolutions","volume":"28","author":"Elkington","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010030","article-title":"Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs","volume":"5","author":"Gil","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.07.011_bb0180","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","article-title":"Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control","volume":"55","author":"Gideon","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.07.011_bb0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ceb.2015.06.006","article-title":"The regulation of immune cell trafficking by the extracellular matrix","volume":"36","author":"Hallmann","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0190","article-title":"Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD","volume":"14","author":"Gupte","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.07.011_bb0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0200","doi-asserted-by":"crossref","first-page":"33162","DOI":"10.1038\/srep33162","article-title":"Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination","volume":"6","author":"Polena","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2024.07.011_bb0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41591-020-0770-2","article-title":"Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions","volume":"26","author":"Ordonez","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0215","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1021\/acs.analchem.1c03462","article-title":"Do anti-tuberculosis drugs reach their target? Horizontal line high-resolution matrix-assisted laser desorption\/ionization mass spectrometry imaging provides information on drug penetration into necrotic granulomas","volume":"94","author":"Kokesch-Himmelreich","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molmed.2024.07.011_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011847","article-title":"Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas","volume":"20","author":"Datta","year":"2024","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0225","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00506-21","article-title":"Lesion penetration and activity limit the utility of second-line injectable agents in pulmonary tuberculosis","volume":"65","author":"Ernest","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molmed.2024.07.011_bb0230","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/s41379-020-0600-6","article-title":"Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence","volume":"33","author":"Abengozar-Muela","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/EDBK_237987","article-title":"Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies","volume":"39","author":"Datta","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.molmed.2024.07.011_bb0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.molmed.2024.07.011_bb0245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41590-021-01121-x","article-title":"The immunoregulatory landscape of human tuberculosis granulomas","volume":"23","author":"McCaffrey","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0250","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.immuni.2016.09.014","article-title":"Macrophage epithelial reprogramming underlies mycobacterial granuloma formation and promotes infection","volume":"45","author":"Cronan","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.07.011_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.trecan.2020.10.005","article-title":"Life and death decision-making by p53 and implications for cancer immunotherapy","volume":"7","author":"Liu","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.molmed.2024.07.011_bb0260","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/pathogens9030218","article-title":"Intelligent mechanisms of macrophage apoptosis subversion by Mycobacterium","volume":"9","author":"Abdalla","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.molmed.2024.07.011_bb0265","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2024.07.011_bb0270","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41467-023-38093-5","article-title":"Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis","volume":"14","author":"Puttock","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0275","first-page":"5871","article-title":"Hypoxia modifies the polarization of macrophages and their inflammatory microenvironment, and inhibits malignant behavior in cancer cells","volume":"18","author":"Ke","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.molmed.2024.07.011_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3604","article-title":"In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0285","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1038\/ncomms9692","article-title":"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug","volume":"6","author":"Miller","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0290","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1596004","article-title":"Interaction of tumor-associated macrophages and cancer chemotherapy","volume":"8","author":"Larionova","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.molmed.2024.07.011_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0001-2019","article-title":"Mycobacterium tuberculosis: bacterial fitness within the host macrophage","volume":"7","author":"Huang","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.molmed.2024.07.011_bb0300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/mi.2017.60","article-title":"Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques","volume":"11","author":"Kauffman","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0305","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.1901211","article-title":"IL-10 impairs local immune response in lung granulomas and lymph nodes during early Mycobacterium tuberculosis infection","volume":"204","author":"Wong","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102318","article-title":"Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis","volume":"139","author":"Lanni","year":"2023","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.molmed.2024.07.011_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00159-19","article-title":"Caseum: a niche for Mycobacterium tuberculosis drug-tolerant persisters","volume":"33","author":"Sarathy","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2024.07.011_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41115","article-title":"High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types","volume":"7","author":"Blanc","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2024.07.011_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5616","article-title":"Targeting the renin-angiotensin system to improve cancer treatment: implications for immunotherapy","volume":"9","author":"Pinter","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0330","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0335","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-22-1630","article-title":"Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs, and FOXP3+ cancer cells in locally advanced pancreatic cancer","volume":"29","author":"Boucher","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2024.07.011_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006974","article-title":"Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis","volume":"14","author":"Xu","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.07.011_bb0345","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(15)70053-8","article-title":"Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Daley","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molmed.2024.07.011_bb0350","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3945\/ajcn.115.113886","article-title":"High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial","volume":"102","author":"Tukvadze","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.molmed.2024.07.011_bb0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2009.06.009","article-title":"Effect of 1, 25 dihydroxyvitamin D3 on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis","volume":"133","author":"Anand","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2567.2008.03024.x","article-title":"1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection","volume":"127","author":"Coussens","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.molmed.2024.07.011_bb0365","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/ijmy.ijmy_120_17","article-title":"Vitamin D, cell death pathways, and tuberculosis","volume":"6","author":"Wahyunitisari","year":"2017","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.07.011_bb0375","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2011.09.010","article-title":"Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis","volume":"10","author":"Napier","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2024.07.011_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011387","article-title":"The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas","volume":"19","author":"Cleverley","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.07.011_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115738","article-title":"Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis","volume":"168","author":"Arnett","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molmed.2024.07.011_bb0390","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.immuni.2021.06.009","article-title":"Macrophage and neutrophil death programs differentially confer resistance to tuberculosis","volume":"54","author":"Stutz","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.07.011_bb0395","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.immuni.2021.07.010","article-title":"Live and let die: TB control by enhancing apoptosis","volume":"54","author":"Arnett","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.07.011_bb0400","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/IAI.70.11.5946-5954.2002","article-title":"Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression","volume":"70","author":"Scott","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chom.2015.06.008","article-title":"Myeloid Growth factors promote resistance to mycobacterial infection by curtailing granuloma necrosis through macrophage replenishment","volume":"18","author":"Pagan","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2024.07.011_bb0410","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41385-018-0071-y","article-title":"A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis","volume":"11","author":"Dunlap","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0415","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/IAI.67.8.3786-3792.1999","article-title":"CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection","volume":"67","author":"Kirman","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molmed.2024.07.011_bb0420","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52668","article-title":"Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-alpha","volume":"9","author":"Tezera","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2024.07.011_bb0425","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf3861","article-title":"PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques","volume":"6","author":"Kauffman","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0430","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02512-2021","article-title":"The paradox of immune checkpoint inhibition re-activating tuberculosis","volume":"60","author":"Ahmed","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.molmed.2024.07.011_bb0435","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2020.03.015","article-title":"Immune checkpoint inhibitor use and tuberculosis: a systematic review of the literature","volume":"132","author":"Zaemes","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.molmed.2024.07.011_bb0440","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1164\/rccm.201807-1250LE","article-title":"Implications of tuberculosis reactivation after immune checkpoint inhibition","volume":"198","author":"Elkington","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0445","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163101","article-title":"Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy","volume":"8","author":"Singh","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2024.07.011_bb0450","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1073\/pnas.1711373114","article-title":"In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of Mycobacterium tuberculosis","volume":"115","author":"Gautam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.07.011_bb0455","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1073\/pnas.1318415110","article-title":"Combining two strategies to improve perfusion and drug delivery in solid tumors","volume":"110","author":"Stylianopoulos","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.07.011_bb0460","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0465","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.07.011_bb0470","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0475","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2024.07.011_bb0480","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm879","article-title":"Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation","volume":"9","author":"Brown","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.07.011_bb0485","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.07.011_bb0490","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","article-title":"Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy","volume":"6","author":"Incio","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molmed.2024.07.011_bb0495","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma","volume":"38","author":"Van Cutsem","year":"2020","journal-title":"J. Clin. Oncol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:30:09Z","timestamp":1736425809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1471491424002053"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.07.011","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging insights from cancer to improve tuberculosis therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}